Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear transit of human zipcode-binding protein IMP1.

Jacob Nielsen1, Sidsel K Adolph, Ewa Rajpert-De Meyts

  • 1Institute of Molecular Biology, University of Copenhagen, Copenhagen, Denmark.

The Biochemical Journal
|August 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting Survey.

The American journal of surgical pathology·2026
Same author

Widespread mono- and oligoadenylation direct small noncoding RNA maturation versus degradation fates.

The EMBO journal·2025
Same author

Multiple Quality Control Checkpoints Safeguard Small Nuclear RNA Biogenesis and Prevent Assembly of Aberrant Spliceosomes.

bioRxiv : the preprint server for biology·2025
Same author

EndoCompass Project: Research Roadmap for Reproductive and Developmental Endocrinology.

Hormone research in paediatrics·2025
Same author

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

NPJ genomic medicine·2025
Same author

The Molecular Mechanism of PDE1 Regulation.

Cells·2025
Same journal

Mechanistic insights into acetylated histone recognition by the CECR2 bromodomain.

The Biochemical journal·2026
Same journal

Nanobodies against Plasmodium adhesins that block receptor engagement and malaria parasite invasion.

The Biochemical journal·2026
Same journal

Persistence without turnover: the RhoG G12E mutant highlights the role of nucleotide cycling in RhoG signaling.

The Biochemical journal·2026
Same journal

Alternative Splicing of Rice Chloroplastic CuZn Superoxide Dismutase, OsCSD2: Impact on expression and protein characteristics.

The Biochemical journal·2026
Same journal

Difference and similarity between the ubiquitous secretory pathway Ca2+-ATPases, SERCA2b, and SPCA1a.

The Biochemical journal·2026
Same journal

A molecular perspective on dimethylarginine dimethylaminohydrolases structure and function.

The Biochemical journal·2026
See all related articles

This study investigates how the protein IMP1 moves between the cell nucleus and the cytoplasm. Researchers discovered that IMP1 can enter the nucleus, a process influenced by its ability to bind RNA. The study also identifies specific signals that help the protein exit the nucleus, suggesting it may interact with genetic material before it reaches the rest of the cell.

Area of Science:

  • Cell biology research involving IMP1 nuclear trafficking
  • Molecular genetics and RNA processing studies

Background:

No prior work had resolved the full intracellular movement patterns of the insulin-like growth factor II mRNA-binding protein family. These proteins are known to regulate how genetic messages are stored and used within the cytoplasm. That uncertainty drove researchers to examine whether these molecules also operate inside the nucleus. Prior research has shown that these proteins contain specific structural motifs for interacting with genetic material. However, the exact mechanisms governing their transit across the nuclear envelope remained unclear. This gap motivated a closer look at the protein's localization in different cell types. Scientists previously focused on cytoplasmic roles, often overlooking potential nuclear activities. The current investigation addresses this by characterizing the protein's presence in both experimental and human tissue models.

Purpose Of The Study:

The aim of this study is to characterize the nuclear transit capabilities of the human IMP1 protein. Researchers sought to determine if this protein, primarily known for cytoplasmic functions, can enter the nuclear compartment. They investigated the signals and conditions that govern its movement across the nuclear envelope. The study addresses the lack of information regarding the protein's potential role in nuclear gene regulation. By identifying specific structural motifs, the team explored how the protein exits the nucleus. They also examined whether the protein's interaction with genetic material influences its localization. This investigation was motivated by the need to understand how the protein defines the fate of genetic transcripts. The researchers provide evidence that the protein's movement is a highly regulated process.

Keywords:
RNA-binding proteinsnuclear export signalsgene regulationcellular trafficking

Frequently Asked Questions

The researchers propose that IMP1 enters the nucleus when its RNA-binding capacity is disrupted. This mechanism suggests that the protein's ability to form cytoplasmic granules regulates its transit, rather than relying on a conventional import signal.

The protein utilizes two distinct nuclear export signals located within its K homology domains. The first signal, found in domain 2, is sensitive to leptomycin B, while the second signal in domain 4 remains unaffected by this specific inhibitor.

The study indicates that the protein does not possess a simple import signal. Instead, nuclear entry is facilitated by the disruption of RNA binding and the reduction of cytoplasmic granule formation, which are necessary conditions for nuclear translocation.

The researchers utilized NIH 3T3 fibroblasts for experimental observations and examined human spermatogenic cells to confirm the presence of the protein within nuclear compartments. These models allowed for the detection of immunoreactivity in both controlled and biological settings.

Related Experiment Videos

Main Methods:

The review approach involved analyzing the intracellular distribution of the protein in cultured fibroblast lines. Researchers utilized immunofluorescence techniques to visualize the protein's localization within the cellular compartments. They performed experiments to test how the inhibition of specific binding activities influenced protein movement. The team evaluated the role of structural domains by examining the effects of mutations on nuclear transit. They also assessed the sensitivity of export signals to leptomycin B treatment. Comparison between different cell types provided evidence for the protein's presence in human tissue. The study integrated these observations to map the pathways used for crossing the nuclear envelope. This methodology allowed for the identification of two distinct export signals within the protein structure.

Main Results:

Key findings from the literature demonstrate that IMP1 is capable of translocating into the nuclei of NIH 3T3 fibroblasts. Immunoreactivity for the protein is also detectable within the nuclei of human spermatogenic cells. The protein does not contain a simple import signal for nuclear entry. Instead, nuclear translocation is facilitated by the disruption of RNA binding and the formation of cytoplasmic granules. The study identifies two nuclear export signals located within the K homology domains 2 and 4. The signal in domain 2 is a leucine-rich sequence that is sensitive to leptomycin B. In contrast, the signal in domain 4 is insensitive to this chemical inhibitor. These results suggest that the protein may attach to target mRNAs while inside the nucleus.

Conclusions:

The authors propose that this protein likely associates with genetic transcripts while still inside the nucleus. This interaction may serve to pre-determine the subsequent behavior of these messages once they reach the cytoplasm. The findings suggest that the protein utilizes distinct pathways for exiting the nuclear compartment. One pathway relies on a leucine-rich signal that is sensitive to specific chemical inhibitors. A second exit route operates independently of such inhibition, indicating a complex regulatory mechanism. The researchers conclude that the protein does not rely on a standard import signal for entering the nucleus. Instead, its nuclear entry appears linked to the state of its binding activity with genetic material. These observations provide a framework for understanding how the protein influences post-transcriptional gene regulation.

The researchers measured the protein's localization using immunoreactivity assays. They observed that the protein is present in the nuclei of human spermatogenic cells and can translocate into the nuclei of cultured fibroblasts.

The authors propose that IMP1 attaches to target mRNAs within the nucleus to define the cytoplasmic fate of these transcripts. This implies that the protein's nuclear transit is a regulatory step for gene expression.